AMY BUSTIN: Open Payments
NPI 1982643920 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,808 in 72 payments from 23 companies in 2025. Trend: 2023 $1,215 · 2024 $1,720 · 2025 $1,808
Food & beverage: $1,808
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $366 |
| SK Life Science, Inc. | 6 | $228 |
| Ceribell, Inc. | 1 | $144 |
| PFIZER INC. | 6 | $141 |
| ACADIA Pharmaceuticals Inc | 6 | $132 |
| Amgen Inc. | 1 | $131 |
| MDD US Operations, LLC | 3 | $90 |
| Amneal Pharmaceuticals LLC | 4 | $82 |
| Teva Pharmaceuticals USA, Inc. | 4 | $66 |
| Lundbeck LLC | 2 | $52 |
Products named: BOTOX, POCKET EEG DEVICE, NUPLAZID, REPATHA, QULIPTA, NURTEC ODT, ONGENTYS, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
